FSD Pharma Inc. Files Form 6-K
Ticker: QNTM · Form: 6-K · Filed: Apr 9, 2024 · CIK: 1771885
| Field | Detail |
|---|---|
| Company | Fsd Pharma Inc. (QNTM) |
| Form Type | 6-K |
| Filed Date | Apr 9, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: reporting, foreign-private-issuer, pharmaceuticals
TL;DR
FSD Pharma Inc. filed a 6-K on 4/9/24, standard reporting for a Canadian company.
AI Summary
FSD Pharma Inc. filed a Form 6-K on April 9, 2024, reporting for the month of April 2024. The company is incorporated in Ontario, Canada, with its principal executive offices located at 199 Bay Street, Suite 4000, Toronto, Ontario M5L 1A9. FSD Pharma Inc. operates in the Pharmaceutical Preparations industry.
Why It Matters
This filing indicates ongoing reporting requirements for FSD Pharma Inc. with the SEC, providing transparency to investors about its corporate status and operations.
Risk Assessment
Risk Level: low — This is a routine filing for a foreign private issuer and does not contain significant new financial or operational information.
Key Players & Entities
- FSD Pharma Inc. (company) — Filer of the Form 6-K
- April 9, 2024 (date) — Filing date of the Form 6-K
- Toronto, Ontario M5L 1A9 (location) — Principal executive offices address
- 2834 (industry_code) — Standard Industrial Classification for Pharmaceutical Preparations
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is filed by foreign private issuers to report information that they have made or are required to make public in their home country, or that they have filed or are required to file with a stock exchange on which they are traded.
What is FSD Pharma Inc.'s Standard Industrial Classification code?
FSD Pharma Inc.'s Standard Industrial Classification code is 2834, which corresponds to Pharmaceutical Preparations.
Where are FSD Pharma Inc.'s principal executive offices located?
FSD Pharma Inc.'s principal executive offices are located at 199 Bay Street, Suite 4000, Toronto, Ontario M5L 1A9.
Is FSD Pharma Inc. filing an annual report under Form 20-F or Form 40-F?
FSD Pharma Inc. is indicating it files or will file annual reports under cover of Form 40-F.
What is the filing date of this Form 6-K?
This Form 6-K was filed on April 9, 2024.
Filing Stats: 302 words · 1 min read · ~1 pages · Grade level 11.4 · Accepted 2024-04-09 16:57:10
Filing Documents
- form6k.htm (6-K) — 6KB
- exhibit99-1.htm (EX-99.1) — 10KB
- 0001062993-24-008203.txt ( ) — 17KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. FSD Pharma Inc. (Registrant) Date: April 8, 2024 By: /s/ Nathan Coyle Nathan Coyle, Chief Financial Officer